Clinical Investigation Exploring a Newly Developed Ostomy Baseplate
1 other identifier
interventional
20
1 country
1
Brief Summary
Peristomal skin complications (PSCs) are the predominant complication for people living with a stoma, which affect their quality of life negatively. Among the main reasons for developing PSCs are that the peristomal skin is exposed to stomal output either due to leakage of output under the baseplate and/or imperfect cutting of the hole in the baseplate, and incorrect application creating a gap between the hole in the baseplate and the stoma. To seal this gap, Coloplast has developed a new ostomy baseplate and the aim of the investigation is to explore the investigational device 's ability to help protect the peristomal skin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2026
CompletedStudy Start
First participant enrolled
January 24, 2026
CompletedFirst Posted
Study publicly available on registry
January 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 9, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 9, 2026
CompletedMay 1, 2026
January 1, 2026
3 months
January 22, 2026
April 30, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Maximum itching scale 0-10)
Itching score (weekly max at steady state\* scale 0-10). \* To account for a possible carry-over effect, the steady state period of the treatment period begins after two weeks of investigational device or comparator use. It is anticipated that the skin will have adapted to the new device after two weeks.
8 weeks
Study Arms (2)
Investigational device
EXPERIMENTAL4 weeks treatment with investigational device
Comparator
ACTIVE COMPARATOR4 weeks treatment with investigational device
Interventions
Eligibility Criteria
You may qualify if:
- Has given written consent
- Is at least 18 years of age
- Has full legal capacity
- Has an ileostomy with consistent liquid fecal output (6-7 Bristol scale).
- Has had the stoma for at least 90 days.
- Has a stoma size less than 40mm in diameter
- Has experienced leakage under the baseplate at least three times within the last 14 days.
- Leakage defined as output/seeping under the baseplate (see Appendix A)
- Has experienced symptoms of peristomal skin complications such as itching, burning, or pain in the peristomal area within the last 14 days.
- Has suitable peristomal skin area (assessed by investigator)
- Is able to handle the electronic diary (questionnaire/photo) themselves. If needed, a trained spouse or caretaker is allowed to assist.
- Is able to handle (apply, remove, etc.) the investigational devices themselves.
- Understands that any supporting products under the baseplate are not permissible during the investigation (except for adhesive removers) and is willing to not use these during the investigation.
- Is willing and suitable (determined by the Principal Investigator or designee) to use a flat 2-piece device during the investigation.
- Is willing to change the baseplate at least every third/fourth day during the investigation.
You may not qualify if:
- Is currently receiving or have within the past 60 days received radio-and/or chemotherapy.
- Low doses radio- and/or chemotherapy (assessed by Principal Investigator) is allowed for other indications than cancer.
- Is currently receiving or have within the past 30 days received topical steroid treatment in the peristomal skin area, e.g., lotion or spray treatment.
- Is breastfeeding.
- Is pregnant based on urine pregnancy test.
- Has known hypersensitivity towards any of the investigational devices used in the investigation.
- Has a complicated stoma at baseline, as assessed by investigator (e.g., dehiscence/prolapse/hernia).
- Daily use of analgesics, antihistamine or steroid treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Coloplast A/Slead
Study Sites (1)
Coloplast A/S
Humlebæk, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2026
First Posted
January 29, 2026
Study Start
January 24, 2026
Primary Completion
April 9, 2026
Study Completion
April 9, 2026
Last Updated
May 1, 2026
Record last verified: 2026-01